Mediators of systemic inflammation, such as nitric oxide, prostaglandins, or cytokines (IL-1β and IL-6), also modify gene expression profile through the activation of DNA methyltransferases (DNMTs) and HDACs, thereby influencing the behavior of cancer cells [140]. The gene discussed is IL1B; the disease is cancer.